| Trial ID: | L7084 |
| Source ID: | NCT03362398
|
| Associated Drug: |
Omarigliptin 25 Mg
|
| Title: |
Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Omarigliptin 25 mg|DRUG: Trelagliptin 100 mg
|
| Outcome Measures: |
Primary: Human plasma concentration of 12 participants will be measured after 1.5 h, The main purpose of this outcome is to check the suitability of the developed LC-MS/MS method for determination of the drugs in human plasma, 2 weeks |
|
| Sponsor/Collaborators: |
Sponsor: British University In Egypt
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2017-11-20
|
| Completion Date: |
2017-11-28
|
| Results First Posted: |
|
| Last Update Posted: |
2017-12-05
|
| Locations: |
The British University in Egypt, Cairo, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT03362398
|
